| Primary |
| Acute Myocardial Infarction |
52.8% |
| Drug Use For Unknown Indication |
9.5% |
| Myocardial Infarction |
8.5% |
| Pulmonary Embolism |
6.2% |
| Ischaemic Stroke |
3.9% |
| Chest Pain |
3.6% |
| Thrombolysis |
2.3% |
| Product Used For Unknown Indication |
2.0% |
| Coronary Artery Disease |
1.6% |
| Hypertension |
1.3% |
| Indwelling Catheter Management |
1.3% |
| Parkinson's Disease |
1.3% |
| Anticoagulant Therapy |
1.0% |
| Anaemia |
0.7% |
| Antiplatelet Therapy |
0.7% |
| Anuria |
0.7% |
| Cerebrovascular Accident |
0.7% |
| Coronary Arterial Stent Insertion |
0.7% |
| Coronary Artery Thrombosis |
0.7% |
| Diabetes Mellitus |
0.7% |
|
| Death |
18.3% |
| Ventricular Fibrillation |
9.9% |
| Thrombosis In Device |
7.0% |
| Cerebrovascular Accident |
5.6% |
| Haemoglobin Decreased |
5.6% |
| Muscle Haemorrhage |
5.6% |
| Pneumonia Aspiration |
5.6% |
| Bacteraemia |
4.2% |
| Haemorrhage Intracranial |
4.2% |
| Multi-organ Failure |
4.2% |
| Ventricular Tachycardia |
4.2% |
| Cardio-respiratory Arrest |
2.8% |
| Coronary Artery Stenosis |
2.8% |
| Haematemesis |
2.8% |
| Haematoma |
2.8% |
| Hemiparesis |
2.8% |
| Incision Site Haemorrhage |
2.8% |
| Ischaemic Stroke |
2.8% |
| Post Procedural Complication |
2.8% |
| Post Procedural Myocardial Infarction |
2.8% |
|
| Secondary |
| Drug Use For Unknown Indication |
21.7% |
| Myocardial Infarction |
21.7% |
| Pericarditis |
16.3% |
| Acute Myocardial Infarction |
6.5% |
| Chest Pain |
6.5% |
| Product Used For Unknown Indication |
4.4% |
| Anticoagulant Therapy |
3.7% |
| Thrombolysis |
3.5% |
| Coronary Arterial Stent Insertion |
1.9% |
| Parkinson's Disease |
1.9% |
| Pulmonary Embolism |
1.9% |
| Stent Placement |
1.6% |
| Acute Coronary Syndrome |
1.4% |
| Catheterisation Cardiac |
1.4% |
| Platelet Aggregation Inhibition |
1.4% |
| Hypertension |
1.2% |
| Indwelling Catheter Management |
0.9% |
| Ischaemic Stroke |
0.9% |
| Acute Myocardial Infarction, Of Other Inferior Wall |
0.7% |
| Anaemia |
0.5% |
|
| Tachypnoea |
12.9% |
| Pulseless Electrical Activity |
11.3% |
| Death |
9.7% |
| Uterine Leiomyoma |
9.7% |
| Haemorrhage Intracranial |
6.5% |
| Ventricular Fibrillation |
6.5% |
| Bacteraemia |
4.8% |
| Cerebral Haemorrhage |
4.8% |
| Visual Disturbance |
4.8% |
| Adverse Drug Reaction |
3.2% |
| Cardiac Arrest |
3.2% |
| Haemorrhage |
3.2% |
| Obstructive Airways Disorder |
3.2% |
| Subarachnoid Haemorrhage |
3.2% |
| Visual Acuity Reduced |
3.2% |
| Wound Secretion |
3.2% |
| Anuria |
1.6% |
| Cardiac Tamponade |
1.6% |
| Coronary Artery Dissection |
1.6% |
| Drug Toxicity |
1.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
18.2% |
| Acute Myocardial Infarction |
15.2% |
| Product Used For Unknown Indication |
15.2% |
| Fluid Retention |
12.1% |
| Vasodilation Procedure |
12.1% |
| Coronary Artery Bypass |
6.1% |
| Hypertension |
6.1% |
| Pain |
6.1% |
| Coronary Angioplasty |
3.0% |
| Myocardial Infarction |
3.0% |
| Percutaneous Coronary Intervention |
3.0% |
|
| Haemorrhage Intracranial |
27.3% |
| Anaphylactic Shock |
9.1% |
| Cerebral Haemorrhage |
9.1% |
| Death |
9.1% |
| Fear |
9.1% |
| Haematemesis |
9.1% |
| Haemoptysis |
9.1% |
| Injury |
9.1% |
| Ischaemic Cerebral Infarction |
9.1% |
|
